IN THIS ISSUE
Legislation & Regulation
John Carroll
The gray market, where medications can be repriced, is becoming unmanageable
Medication Management
Thomas Reinke
Decision support tools provide new options for oncologists and health plans
Plan Watch
Frank Diamond
Holding physicians to best-practice guidelines with the threat of refusing to pay for unnecessary tests reaps dividends
Tomorrow's Medicine
Thomas Morrow, MD
Managed care once again faces the all-too-familiar debate about cost and benefit
Managed Care Outlook
Lipitor led the way, and other blockbusters are following
News & Commentary
News & Commentary